These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 35160128)

  • 1. Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review.
    Alijotas-Reig J; Esteve-Valverde E; Anunciación-Llunell A; Marques-Soares J; Pardos-Gea J; Miró-Mur F
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Hoxha A; Tincani A; Nalli C; Marozio L; Maina A; Espinosa G; Ríos-Garcés R; Cervera R; Carolis S; Monteleone G; Latino O; Udry S; LLurba E; Garrido-Gimenez C; Trespidi L; Gerosa M; Chighizola CB; Rovere-Querini P; Canti V; Mayer-Pickel K; Tabacco S; Arnau A; Trapé J; Ruiz-Hidalgo D; Sos L; Farran-Codina I;
    Rheumatology (Oxford); 2020 Jun; 59(6):1306-1314. PubMed ID: 31580459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].
    Gao R; Qin L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):513-520. PubMed ID: 38948301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; LLurba E; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Espinosa G; de Carolis S; Rovere-Querini P; Lundelin K; Picardo E; Mekinian A;
    Med Clin (Barc); 2018 Sep; 151(6):215-222. PubMed ID: 29274674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first year report.
    Alijotas-Reig J; Ferrer-Oliveras R;
    Lupus; 2012 Jun; 21(7):766-8. PubMed ID: 22635227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
    Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases.
    Alijotas-Reig J; Esteve-Valverde E; Llurba E; Gris JM
    Semin Arthritis Rheum; 2019 Oct; 49(2):314-318. PubMed ID: 30824278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical phenotype, treatment strategy and pregnancy outcome of non-criteria obstetric antiphospholipid syndrome.
    Li J; Hou Y; Zhang L; Li F; Liu Q; Li Y; Shen H; Xiong Z; Huang L; Qiao C
    Am J Reprod Immunol; 2023 Jun; 89(6):e13684. PubMed ID: 36756665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group.
    Esteve-Valverde E; Alijotas-Reig J; Belizna C; Marques-Soares J; Anunciacion-Llunell A; Feijóo-Massó C; Sáez-Comet L; Mekinian A; Ferrer-Oliveras R; Lefkou E; Morales-Pérez S; Hoxha A; Tincani A; Nalli C; Pardos-Gea J; Marozio L; Maina A; Espinosa G; Cervera R; De Carolis S; Latino O; Udry S; Llurba E; Garrido-Gimenez C; Trespidi L; Gerosa M; Chighizola CB; Rovere-Querini P; Canti V; Mayer-Pickel K; Tabacco S; Arnau A; Miró-Mur F
    Placenta; 2023 May; 136():29-34. PubMed ID: 37028222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and pregnancy outcomes of non-criteria obstetric antiphospholipid syndrome].
    Yang XX; Sun YD; Zhao JL; Tian XP; Zeng XF; Li MT
    Zhonghua Nei Ke Za Zhi; 2021 Sep; 60(9):812-816. PubMed ID: 34445817
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of placental lesions in patients with systemic lupus erythematosus, antiphospholipid syndrome and non-criteria obstetric antiphospholipid syndrome and adverse perinatal outcomes.
    Castellanos Gutierrez AS; Figueras F; Espinosa G; Youssef L; Crispi F; Santana M; Nadal A; Baños N
    Placenta; 2023 Aug; 139():92-98. PubMed ID: 37354691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetric antiphospholipid syndrome.
    Antovic A; Sennström M; Bremme K; Svenungsson E
    Lupus Sci Med; 2018; 5(1):e000197. PubMed ID: 30364418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms.
    D'Ippolito S; Barbaro G; Paciullo C; Tersigni C; Scambia G; Di Simone N
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort.
    Alijotas-Reig J; Ferrer-Oliveras R; Esteve-Valverde E; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Espinosa G; Coloma E; de Carolis S; Rovere-Querini P; Canti V; Picardo E; Fredi M; Mekinian A;
    Am J Reprod Immunol; 2016 Aug; 76(2):164-71. PubMed ID: 27401589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications-a population-based study.
    Rhein AK; Rabinovich A; Abuhasira R; Lubaton-Barshishat S; Erez O
    Res Pract Thromb Haemost; 2024 May; 8(4):102430. PubMed ID: 38798792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome.
    Niznik S; Rapoport MJ; Avnery O; Lubetsky A; Shavit R; Ellis MH; Agmon-Levin N
    Front Pharmacol; 2022; 13():824775. PubMed ID: 35529433
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study.
    Li X; Deng X; Duan H; Zeng L; Zhou J; Liu C; Guo X; Liu X
    Clin Rheumatol; 2021 Jan; 40(1):193-204. PubMed ID: 32514680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An advanced understanding of the heterogeneous clinical features of "non-criteria" obstetric antiphospholipid syndrome: Two case reports and a literature review.
    Peng X; Tan X; Xing A
    Front Immunol; 2023; 14():1122127. PubMed ID: 36865564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases.
    Alijotas-Reig J; Ferrer-Oliveras R; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Coloma-Bazan E; de Carolis S; Espinosa G; Rovere-Querini P; Kuzenko A; Valverde EE; Robles A; Cervera R; Canti V; Fredi M; Gil-Aguado A; Lundelin K; Llurba E; Melnychuk T; Nalli C; Picardo E; Silvestro E; del Ross T; Farran-Codina I;
    Autoimmun Rev; 2015 May; 14(5):387-95. PubMed ID: 25555817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.